THAR – tharimmune, inc. (US:NASDAQ)
Stock Stats
News
Tharimmune (NASDAQ:THAR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Tharimmune (NASDAQ:THAR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
New Crypto Deals Put Retail at Risk After $17 Billion Wipeout [Yahoo! Finance]
Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids
Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy
Form S-3 Tharimmune, Inc.
Form 424B3 Tharimmune, Inc.
Form EFFECT Tharimmune, Inc.
Form 3 Tharimmune, Inc. For: Nov 06 Filed by: Wendland Mark Paul
Form 3 Tharimmune, Inc. For: Nov 06 Filed by: Toomey Mark Christopher
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.